Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Jim Cirigliano
This person does not yet have a bio.
Articles by Jim Cirigliano
| 3 min read
by
Jim Cirigliano
A gut check for Big Pharma
Major biotech-pharma agreement demonstrates potential value of microbiome research
Articles
| 3 min read
by
Jim Cirigliano
Stemming the pain of osteoarthritis
RNL BIO’s stem cell product holds promise of a single-injection treatment for osteoarthritis
Articles
| 3 min read
by
Jim Cirigliano
A partnership of VAST consequence
Proprietary chemistry platform will aid development of novel small molecules against multiple targets
Articles
| 3 min read
by
Jim Cirigliano
Laying a foundation for hematologic diagnostics
Foundation Medicine, MSKCC to co-develop product that will match patients with targeted therapies or clinical trials for hematologic malignancies
Articles
| 3 min read
by
Jim Cirigliano
From lab to clinic in the Sunshine State
First five projects named to pilot Florida Translational Research Program
Articles
| 3 min read
by
Jim Cirigliano
Nanomedicine: The next (not-so-) big thing
BIND Therapeutics announces collaboration with Pfizer to develop nanoparticle-based therapeutics
Articles
| 3 min read
by
Jim Cirigliano
A rallying point for cancer research
AACR’s Annual Meeting 2013 and Rally for Medical Research draw thousands to nation’s capital
Articles
| 3 min read
by
Jim Cirigliano
Stopping RA before it starts
Research partnership seeks high-value biomarkers and diagnostic test for rheumatoid arthritis
Articles
| 3 min read
by
Jim Cirigliano
DELETED STORY--Stopping RA before it starts
Research partnership seeks high-value biomarkers and diagnostic test for rheumatoid arthritis
Articles
| 3 min read
by
Jim Cirigliano
Covance, M2Gen play matchmaker
Partnership creates ‘one-stop shop’ for matching patients with biomarker-driven oncology trials
Articles
| 2 min read
by
Jim Cirigliano
High-profile oncology partnership
Araxes Pharma and Janssen Biotech ink oncology drug development deal
Articles
| 3 min read
by
Jim Cirigliano
MAP leads to pot of gold
Allergan subsidiary, MAP Pharmaceuticals merger could be worth nearly $1 billion
Articles
Page 6 of 8 - 95 Total Items
1
2
3
4
5
6
7
8
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
A scientist's guide to electronic laboratory notebook selection
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.
Articles
Mini Masterclass: Weighing best practices for accurate analytical results
Learn the fundamental weighing principles and operational controls that support reliable sample preparation.
Webinars
How new alternative methods are changing drug safety testing
Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.
Video
Latest Issue
Volume 21 • Issue 4 • December 2025
December 2025
December 2025 Issue
Explore this issue